|
Index of reports
> Cases with Sepsis (153)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Methotrexate where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 153 Next >>
Possible Methotrexate side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Methotrexate side effects in 69 year old female
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: 69 year old female, weighing 80.7 kg (177.6 pounds)
Reactions: Pneumonia, Hypotension, Anaemia, Encephalopathy, Hyponatraemia, Rheumatoid Arthritis, Sepsis, Dehydration, Altered State of Consciousness, Type 1 Diabetes Mellitus, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cimzia
Dosage: 400 mug, unk
Indication: Rheumatoid Arthritis
Start date: 2012-02-01
Methotrexate
Dosage: 7.5 mg, unk
Administration route: Oral
Indication: Rheumatoid Arthritis
Prednisone TAB
Dosage: 8 mg, qd
Administration route: Oral
Indication: Rheumatoid Arthritis
Prolia
Dosage: 60 mg, q6mo
Indication: Osteoporosis Postmenopausal
Start date: 2010-01-01
End date: 2012-07-05
Other drugs received by patient: Diovan HCT; Nexium
Possible Methotrexate side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Methotrexate side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-02
Patient: male, weighing 119.8 kg (263.5 pounds)
Reactions: Diabetes Mellitus, Abasia, Perineal Cyst, Decreased Immune Responsiveness, Intervertebral Disc Degeneration, Abnormal Loss of Weight, Oxygen Saturation Decreased, Intervertebral Disc Protrusion, Fistula, Gout, Convulsion, Cholelithiasis, Diarrhoea, Sepsis, Heart Rate Increased, Arthritis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Colchicine
Administration route: Oral
Indication: Gout
Start date: 2012-05-01
Levemir
Dosage: 52 units/ at night/subcutaneous
Indication: Diabetes Mellitus
Methotrexate
Administration route: Oral
Indication: Intervertebral Disc Protrusion
Start date: 2011-01-01
End date: 2011-01-01
Novolog
Dosage: 40 units/solution before meals
Indication: Diabetes Mellitus
Start date: 2011-01-01
End date: 2011-01-01
Remicade
Indication: Crohn's Disease
Start date: 2004-09-09
End date: 2010-01-01
Remicade
Start date: 2010-01-01
Other drugs received by patient: Flomax; Dilaudid; Ambien; Valium; Hydrochlorothiazide; Cymbalta; Lyrica; Lisinopril; Simvastatin; Nexium; Humalog; Onglyza
Possible Methotrexate side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: last dose on 16jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cytarabine
Dosage: last dose:17jun12 route:intra ommya
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Dexamethasone
Dosage: last dose:16jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Doxorubicin HCL
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Filgrastim
Dosage: last dose:18jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
End date: 2012-01-01
Leucovorin Calcium
Dosage: last dose :21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Mesna
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methotrexate
Dosage: last dose:13jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methylprednisolone
Dosage: last dose:21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Sprycel
Dosage: last dose on 26jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Vincristine Sulfate
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-27
Patient: female
Reactions: Iatrogenic Injury, Ischaemic Stroke, Candida Sepsis, Coma, Status Epilepticus, Aplasia, Convulsion, Subarachnoid Haemorrhage, Sepsis, Posterior Reversible Encephalopathy Syndrome, Oedema, Bone Marrow Failure, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-05-24
Cytarabine
Dosage: 40 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
End date: 2012-05-24
Cytarabine
Dosage: 40 mg, unk
Start date: 2012-05-17
Imatinib Mesylate
Dosage: 400 mg, daily
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
End date: 2012-05-26
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-24
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-17
Methotrexate
Dosage: 15 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Aspegic 1000; Flagyl; Clonazepam; Fluconazole; Zyvox; Trandate; Amphotericin B; Depakene; Keppra; Idarubicin HCL; Olmesartan Medoxomil and Hydrochlorothizide; Metformin Hydrochloride; Fenofibrate; Vincristine; Vincristine; Vancomycin; Aspegic 1000; Bactrim DS; Mesna; Colimycine; Vibramycin D; Fluconazole; Cyclophosphamide; Cyclophosphamide; Tazobactam; Pyostacine; Idarubicin HCL; Methylprednisolone; Ciprofloxacin Hydrochloride; Heparin Sodium; Idarubicin HCL; Ventolin; Valacyclovir Hydrochloride; Mesna; Amikacin; Imipenem and Cilastatin Sodium; Vfend; Idarubicin HCL; Vincristine; Gentamicin; Rocephin; Fosphenytoin Sodium
Possible Methotrexate side effects in 81 year old female
Reported by a physician from Japan on 2012-07-20
Patient: 81 year old female
Reactions: Death, Bronchopulmonary Aspergillosis, Interstitial Lung Disease, Cerebral Infarction, Sepsis, Oral Disorder, Disseminated Intravascular Coagulation, Bone Marrow Failure, Melaena
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Methotrexate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-01
Remicade
Indication: Rheumatoid Arthritis
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-13
Patient: female
Reactions: Ischaemic Stroke, Coma, Status Epilepticus, Aplasia, Convulsion, Subarachnoid Haemorrhage, Posterior Reversible Encephalopathy Syndrome, Sepsis, Oedema, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depocyt
Dosage: 40 mg, unk
Start date: 2012-05-24
Depocyt
Dosage: 40 mg, unk
Start date: 2012-05-17
Depocyt
Dosage: 40 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
Imatinib Mesylate
Dosage: 400 mg, daily
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
End date: 2012-05-26
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-17
Methotrexate
Dosage: 15 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-07
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-05-24
Other drugs received by patient: Aspegic 1000; Bactrim DS; Tazobactam; Imipenem and Cilastatin Sodium; Fluconazole; Amikacin; Vincristine; Vibramycin D; Aspegic 1000; Fosphenytoin Sodium; Keppra; Vincristine; Gentamicin; Cyclophosphamide; Mesna; Colimycine; Pyostacine; Depakene; Iradubicin; Iradubicin; Fluconazole; Vincristine; Methylprednisolone; Ciprofloxacin Hydrochloride; Vancomycin; Mesna; Vfend; Iradubicin; Rocephin; Heparin Sodium; Flagyl; Amphotericin B; Zyvox; Clonazepam; Iradubicin; Valacyclovir Hydrochloride; Cyclophosphamide
Possible Methotrexate side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-11
Patient: 59 year old male, weighing 69.0 kg (151.8 pounds)
Reactions: Pneumonia, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Methotrexate
Indication: Psoriatic Arthropathy
Start date: 2003-01-01
Remicade
Dosage: second dose
Start date: 2010-07-22
Remicade
Dosage: seventh dose
Indication: Psoriatic Arthropathy
End date: 2011-05-04
Remicade
Dosage: fourth dose
Start date: 2010-10-20
Remicade
Dosage: fifth dose
Start date: 2010-12-21
Remicade
Dosage: first dose
Start date: 2010-07-08
Remicade
Dosage: third dose
Start date: 2010-08-23
Remicade
Dosage: sixth dose
Start date: 2011-02-16
Other drugs received by patient: Arava; Lubor; Sulfasalazine; Prednisone TAB; Pantoprazole; Folic Acid
Possible Methotrexate side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2
Cyclophosphamide
Dosage: 250 mg/m2, bid for six doses
Indication: non-Hodgkin's Lymphoma
Cytarabine
Dosage: 100 mg/m2, daily x 5 days
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 30 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 60 mg/m2, single
Hydrocortisone Acetate
Dosage: given with methotrexate
Indication: non-Hodgkin's Lymphoma
Hydrocortisone Acetate
Dosage: given with cytarabine
Methotrexate
Dosage: 3000 mg/m2, single
Methotrexate
Dosage: given with hydrocortisone twice x 2
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 1500 mg/m2, single
Prednisolone
Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
Indication: non-Hodgkin's Lymphoma
Prednisolone
Dosage: 60 mg/m2, daily for 7 days
Rituximab
Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg/m2, single
Vincristine
Dosage: 1 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Possible Methotrexate side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-09
Patient: 59 year old male, weighing 69.0 kg (151.8 pounds)
Reactions: Pneumonia, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Methotrexate
Indication: Psoriatic Arthropathy
Start date: 2003-01-01
Remicade
Dosage: first dose
Start date: 2010-07-08
Remicade
Dosage: fifth dose
Start date: 2010-12-21
Remicade
Dosage: fourth dose
Start date: 2010-10-20
Remicade
Dosage: third dose
Start date: 2010-08-23
Remicade
Dosage: second dose
Start date: 2010-07-22
Remicade
Dosage: seventh dose
Indication: Psoriatic Arthropathy
End date: 2011-05-04
Remicade
Dosage: sixth dose
Start date: 2011-02-16
Other drugs received by patient: Lubor; Folic Acid; Prednisone TAB; Arava; Sulfasalazine; Pantoprazole
Possible Methotrexate side effects in 10 year old female
Reported by a physician from United States on 2012-07-06
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Drug Tolerance Decreased, Renal Failure, Sepsis, Pancytopenia, Febrile Neutropenia, Toxicity To Various Agents, Hypertension, Abdominal Compartment Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Other drugs received by patient: Methotrexate / Hydrocortisone; Rituximab; Prednisolone; Cyclophosphamide; Doxorubicin HCL; Cytarabine / Hydrocortisone); Vincristine; Cytarabine
Possible Methotrexate side effects in 77 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-06
Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-30
Pinorubin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-25
Prednisolone
Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-31
Sprycel
Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-28
End date: 2010-08-22
Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid
Possible Methotrexate side effects in 18 month old male
Reported by a physician from United States on 2012-07-06
Patient: 18 month old male, weighing 11.4 kg (25.1 pounds)
Reactions: Sepsis, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Dexamethasone Sodium Phosphate
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Dexamethasone Sodium Phosphate
Etoposide
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Lestaurtinib
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Lestaurtinib
Mercaptopurine
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Methotrexate
Vincristine
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-04-18
Possible Methotrexate side effects in female
Reported by a physician from India on 2012-07-02
Patient: female, weighing 61.5 kg (135.3 pounds)
Reactions: Multi-Organ Failure, Overdose, Sepsis, Bone Marrow Failure, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Blinded Gp2013
Dosage: code not broken
Start date: 2011-12-20
Blinded Mabthera
Dosage: code not broken
Start date: 2011-12-20
Blinded NO Treatment Received
Dosage: code not broken
Start date: 2011-12-20
Methotrexate
Dosage: 20 mg, qw
Indication: Rheumatoid Arthritis
Start date: 2010-09-13
Other drugs received by patient: Folic Acid; Prednisolone; Glimepiride W / Metformin; Sulfasalazine; Isoniazid; Iron Pentacarbonyl; Calcium Carbonate; Pyridoxine HCL; Acetaminophen; Rabeprazole Sodium; Telmisartan and Hydrochlorothiazide; Hydroxychloroquine Sulfate; Aceclofenac
Possible Methotrexate side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-29
Patient: male
Reactions: Pneumonia, Staphylococcal Infection, Cardiac Failure, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Actemra
Dosage: 560 mg hver 4. uge
Indication: Rheumatoid Arthritis
Start date: 2010-08-01
End date: 2012-02-23
Methotrexate
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Prednisolone
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: female
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (100 mg/m2 on days 1-14 oral)
Administration route: Oral
Indication: Breast Cancer
Fluorouracil
Dosage: (600 mg/m2 ondays 1 and 8 intravenous (not otherwise specified))
Indication: Breast Cancer
Methotrexate
Dosage: (40 mg/m2 on days 1 and 8 intravenous (not otherwise specified))
Indication: Breast Cancer
Possible Methotrexate side effects in 14 year old female
Reported by a physician from United States on 2012-06-28
Patient: 14 year old female, weighing 60.4 kg (132.9 pounds)
Reactions: Stomatitis, Hypotension, Encephalopathy, Acidosis, Hypercalcaemia, Respiratory Failure, Sepsis, Posterior Reversible Encephalopathy Syndrome, Hypocalcaemia, Enterocolitis, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: unk
Indication: Candida Test Positive
Start date: 2012-05-20
Calcium Gluconate
Cefepime
Dosage: unk
Indication: Klebsiella Infection
Start date: 2012-05-10
Dexamethasone Sodium Phosphate
Dosage: 10 mg/m2, bid or iv on days 1-5 and 15-19
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Methotrexate
Dosage: 8-15 mg (age based dosing) it on days 1 (or up to 72 hours prior to day 1) and 8
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, over 30 minutes on days 1 and 2
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Pegaspargase
Dosage: 2500 iu/m2 over 1 hr on days 3 and 17
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Temsirolimus
Dosage: 7.5 mg/m2, over 30 minutes on days i, 8 and 15 (max dose: 15 mg)
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Vincristine
Dosage: 1.5 mg/m2 cyclic (max 2 mg) over i-5 minutes or infusion via mini bag on days 1, 8, i5 and 22
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Possible Methotrexate side effects in male
Reported by a physician from Denmark on 2012-06-25
Patient: male
Reactions: Pneumonia, Staphylococcal Infection, Cardiac Failure, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Actemra
Dosage: dosis: 560 mg hver 4. uge
Indication: Rheumatoid Arthritis
Start date: 2010-08-01
End date: 2012-02-23
Methotrexate
Dosage: behandling stoppet pga. mors, drug reported as emthexate
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Prednisolone
Dosage: behandling stoppet pga. mors
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Possible Methotrexate side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Methotrexate
Dosage: as part of copadm2 and cym1
Methotrexate
Dosage: administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm1
Possible Methotrexate side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm2 and cym1
Methotrexate
Dosage: administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of copadm1
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Possible Methotrexate side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Methotrexate
Dosage: 3000 mg/m2; administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Methotrexate
Dosage: as part of copadm2 and cym1
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm1
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Possible Methotrexate side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Pancytopenia, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 250 mg/m2, bid for 6 doses
Cyclophosphamide
Dosage: 250 mg/m2, bid for 6 doses
Cyclophosphamide
Dosage: 300 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: 100 mg/m2, for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: unknown
Doxorubicin HCL
Dosage: 30 mg/m2, unk
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Dosage: intrathecally twice
Hydrocortisone
Hydrocortisone
Dosage: intrathecally twice
Hydrocortisone
Dosage: unknwon
Methotrexate
Dosage: 1500 mg/m2, unk
Methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: intrathecally twice
Methotrexate
Dosage: intrathecally twice
Methotrexate
Dosage: 1500 mg/m2, unk
Methotrexate
Dosage: 30000 mg/m2, unk
Methotrexate
Prednisolone
Dosage: 60 mg/m2, for 5 days, then taper over 3 days
Prednisolone
Dosage: 60 mg/m2, for 5 days then taper over 3 days
Prednisolone
Dosage: 60 mg/m2, per day for 7 days
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: every 2-4 weeks for 5 total doses with cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: cumulative dose of 1875 mg/m2
Vincristine
Dosage: 2 mg/m2, unk
Vincristine
Dosage: 1 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: 1 mg/m2, unk
Possible Methotrexate side effects in male
Reported by a individual with unspecified qualification from Italy on 2012-06-18
Patient: male
Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Burkitt's Lymphoma
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Vincristine Sulfate
Indication: Burkitt's Lymphoma
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: female
Reactions: Metastases To Liver, Sepsis, Metastases To Skin, Endocarditis, Metastases To Kidney, Metastases To Central Nervous System, Metastases To Lung
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Dosage: on day 1, intravenous (not otherwise specifed)
Indication: Gestational Trophoblastic Tumour
Cisplatin
Dosage: on day 1, intravenous (not otherwise specifed)
Indication: Choriocarcinoma
Dactinomycin
Dosage: 0.5 mg milligram(s), on day 8, intravenous (not otherwise specified)
Indication: Choriocarcinoma
Dactinomycin
Dosage: 0.5 mg milligram(s), on day 8, intravenous (not otherwise specified)
Indication: Gestational Trophoblastic Tumour
Methotrexate
Dosage: on day 8
Indication: Gestational Trophoblastic Tumour
Methotrexate
Dosage: on day 8
Indication: Choriocarcinoma
Possible Methotrexate side effects in male
Reported by a physician from Italy on 2012-06-14
Patient: male
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-08
Patient: female, weighing 51.7 kg (113.7 pounds)
Reactions: Pneumonia Aspiration, Sepsis, Atrial Fibrillation, Clostridial Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Letrozole
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-05-24
Methotrexate
Dosage: 25 ml, qw (q weekly)
Indication: Rheumatoid Arthritis
Other drugs received by patient: Avapro; Metoprolol; Metoprolol; Norvasc
Possible Methotrexate side effects in female
Reported by a pharmacist from Philippines on 2012-06-06
Patient: female, weighing 48.0 kg (105.6 pounds)
Reactions: Pneumonia, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Golimumab
Indication: Rheumatoid Arthritis
Start date: 2008-07-25
Golimumab
Start date: 2008-05-21
Golimumab
Start date: 2009-02-25
Golimumab
Start date: 2008-11-19
Golimumab
Start date: 2008-10-10
Golimumab
Start date: 2008-08-13
Golimumab
Start date: 2008-09-10
Golimumab
Start date: 2011-07-06
Golimumab
Start date: 2008-06-21
Methotrexate
Administration route: Oral
Start date: 2007-04-05
End date: 2007-08-30
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2007-09-06
End date: 2008-02-25
Methotrexate
Administration route: Oral
Start date: 2007-03-29
End date: 2007-03-29
Methotrexate
Administration route: Oral
Start date: 2007-03-22
End date: 2007-05-22
Methotrexate
Administration route: Oral
Start date: 2007-02-22
End date: 2007-03-01
Methotrexate
Administration route: Oral
Start date: 2007-03-08
End date: 2007-03-15
Other drugs received by patient: Prednisone; Prednisone; Mobic; Folic Acid; Methotrexate; Neurobion; Caltrate Plus
Possible Methotrexate side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient:
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Elspar
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Prednisolone
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Methotrexate side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient:
Reactions: Sepsis, Toxicity To Various Agents
Adverse event resulted in: death
Drug(s) suspected as cause:
Elspar
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Prednisolone
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Page 1 Next >>
|
